Showing results (721-730 of 769) with videos related to
Sort By:
Pageof 77
Practical Radiation Oncology|May 24, 2024
External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice GuidelineSara Alcorn, Ángel Artal Cortés, Lisa Bradfield, et al.Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 15, 2018
[PHYSICAL, CHEMICAL AND MORPHOLOGICAL URINE EXAMINATION: RECOMMENDATIONS FOR THE POST ANALYTICAL PHASE FROM THE INTERDISCIPLINARY URINALYSIS GROUP (GIAU)]Fabio Manoni, Gianluca Gessoni, Giovanni Battista Fogazzi, et al.Journal of Experimental & Clinical Cancer Research : CR|February 9, 2022
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivativesFederica Barbieri, Alessia Graziana Bosio, Alessandra Pattarozzi, et al.Nature Genetics|August 22, 2018
Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitryAdam D Durbin, Mark W Zimmerman, Neekesh V Dharia, et al.Advances in Radiation Oncology|June 23, 2025
Spinal Instability Neoplastic Score as a Predictor of Vertebral Fracture in Patients Undergoing Radiation Therapy for Spinal Metastases: A Single-Institution StudyPatrick Doyle, Sarah Caplan, Neil Klinger, et al.Biochimica Et Biophysica Acta. Biomembranes|August 20, 2024
Benzohydroxamate and nitrobenzohydroxamate affect membrane order: Correlations between spectroscopic and molecular dynamics to approach tuberculosisLucas Thadeu Felipe Kokuszi, Yago Mendes Paes, Aline Loise Santana Faria, et al.ACR Open Rheumatology|July 3, 2026
DNASE1L3 Deficiency With Novel Missense Variant: Enzymatic and Plasma Fragmentomic Evidence of Pathogenicity and Partial Response to JAK BlockadeAnnel Andrea Leon Tenorio, Takeshi Sugio, Jordan Cheng, et al.International Journal of Laboratory Hematology|October 10, 2017
Performance evaluation of the automated nucleated red blood cell count of five commercial hematological analyzersG Da Rin, M Vidali, F Balboni, et al.Oncotarget|September 15, 2017
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic responseArianna Palladini, Giordano Nicoletti, Alessia Lamolinara, et al.BMC Palliative Care|May 1, 2015
Transcending differences to study the transcendent: an exploratory study of researchers' and chaplains' reflections on interdisciplinary spiritual care research collaborationRichard A Powell, Linda Emanuel, George Handzo, et al.Pageof 77